Aspire Biopharma Holdings, Inc. (ASBP)
NASDAQ: ASBP · Real-Time Price · USD
6.46
-0.08 (-1.30%)
At close: Jun 25, 2026, 4:00 PM EDT
6.20
-0.25 (-3.95%)
After-hours: Jun 25, 2026, 7:06 PM EDT
Aspire Biopharma Holdings Market Cap
Aspire Biopharma Holdings has a market cap or net worth of $8.36 million as of June 25, 2026. Its market cap has decreased by -54.62% in one year.
Market Cap
8.36M
Enterprise Value
4.00M
1-Year Change
-54.62%
Ranking
Category
Stock Price
$6.46
Market Cap Chart
Since April 11, 2022, Aspire Biopharma Holdings's market cap has decreased from $349.64M to $8.36M, a decrease of -97.61%. That is a compound annual growth rate of -58.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 25, 2026 | 8.36M | -41.02% |
| Dec 31, 2025 | 14.18M | -84.12% |
| Dec 18, 2024 | 89.29M | -8.80% |
| Dec 29, 2023 | 97.91M | -73.55% |
| Dec 30, 2022 | 370.15M | 5.86% |
| Apr 11, 2022 | 349.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cadrenal Therapeutics | 8.78M |
| PharmaCyte Biotech | 8.33M |
| Addex Therapeutics | 8.33M |
| Bolt Biotherapeutics | 8.20M |
| AIM ImmunoTech | 8.02M |
| MetaVia | 7.95M |
| Immuron | 7.92M |
| Curanex Pharmaceuticals | 7.77M |